Prof Tripathy speaks with ecancertv at the Best of ASCO 2016 about modern attitudes to breast cancer care.
He outlines improvements that could help advance patient outcomes, including better modelling options and enhanced immune availability.
Prof Tripathy also considers the evolution of resistance in tumour cells, and of mutations that may be targeted by new therapies.
For more on breast cancer care via the MINDACT trial, click here.